Shanghai Cell Therapy Group Co.,ltd
Clinical trials sponsored by Shanghai Cell Therapy Group Co.,ltd, explained in plain language.
-
Experimental CAR-T therapy targets lupus, ITP, and myositis in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called BZE2204 for people with three autoimmune diseases: lupus, ITP, and inflammatory myopathies. The treatment uses the patient's own immune cells, modified to attack faulty immune cells that cause the disease. The main goals are to …
Phase: EARLY_PHASE1 • Sponsor: Shanghai Cell Therapy Group Co.,Ltd • Aim: Disease control
Last updated May 26, 2026 05:22 UTC
-
Experimental 'Armored' cell shot targets solid cancers in tiny safety trial
Disease control Recruiting nowThis early study is testing a single injection of special immune cells (dendritic cells) that are 'armored' with antibodies to see if they are safe for people with solid tumors like pancreatic, colorectal, or stomach cancer. Only 8 adults who have already had surgery and chemothe…
Phase: PHASE1 • Sponsor: Shanghai Cell Therapy Group Co.,Ltd • Aim: Disease control
Last updated May 18, 2026 11:59 UTC